alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# C_2010016EN.01000701.xml

| 22.1.2010 | EN | Official Journal of the European Union | C 16/7 |
| --- | --- | --- | --- |

22.1.2010

EN

Official Journal of the European Union

C 16/7

---

Euro exchange rates (1)

1

21 January 2010

2010/C 16/04

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,4064 |
| JPY | Japanese yen | 129,14 |
| DKK | Danish krone | 7,4426 |
| GBP | Pound sterling | 0,87000 |
| SEK | Swedish krona | 10,1375 |
| CHF | Swiss franc | 1,4723 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,1455 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,979 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 270,43 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7088 |
| PLN | Polish zloty | 4,0545 |
| RON | Romanian leu | 4,1275 |
| TRY | Turkish lira | 2,0778 |
| AUD | Australian dollar | 1,5463 |
| CAD | Canadian dollar | 1,4740 |
| HKD | Hong Kong dollar | 10,9265 |
| NZD | New Zealand dollar | 1,9590 |
| SGD | Singapore dollar | 1,9725 |
| KRW | South Korean won | 1 599,54 |
| ZAR | South African rand | 10,5954 |
| CNY | Chinese yuan renminbi | 9,6012 |
| HRK | Croatian kuna | 7,2977 |
| IDR | Indonesian rupiah | 13 127,00 |
| MYR | Malaysian ringgit | 4,7501 |
| PHP | Philippine peso | 64,685 |
| RUB | Russian rouble | 41,8618 |
| THB | Thai baht | 46,418 |
| BRL | Brazilian real | 2,5117 |
| MXN | Mexican peso | 17,8760 |
| INR | Indian rupee | 64,7500 |

Currency

Exchange rate

USD

US dollar

1,4064

JPY

Japanese yen

129,14

DKK

Danish krone

7,4426

GBP

Pound sterling

0,87000

SEK

Swedish krona

10,1375

CHF

Swiss franc

1,4723

ISK

Iceland króna

NOK

Norwegian krone

8,1455

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,979

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

270,43

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7088

PLN

Polish zloty

4,0545

RON

Romanian leu

4,1275

TRY

Turkish lira

2,0778

AUD

Australian dollar

1,5463

CAD

Canadian dollar

1,4740

HKD

Hong Kong dollar

10,9265

NZD

New Zealand dollar

1,9590

SGD

Singapore dollar

1,9725

KRW

South Korean won

1 599,54

ZAR

South African rand

10,5954

CNY

Chinese yuan renminbi

9,6012

HRK

Croatian kuna

7,2977

IDR

Indonesian rupiah

13 127,00

MYR

Malaysian ringgit

4,7501

PHP

Philippine peso

64,685

RUB

Russian rouble

41,8618

THB

Thai baht

46,418

BRL

Brazilian real

2,5117

MXN

Mexican peso

17,8760

INR

Indian rupee

64,7500

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
# C_2010089EN.01000101.xml

| 7.4.2010 | EN | Official Journal of the European Union | C 89/1 |
| --- | --- | --- | --- |

7.4.2010

EN

Official Journal of the European Union

C 89/1

---

Non-opposition to a notified concentration

(Case COMP/M.5661 — Abbott/Solvay Pharmaceuticals)

(Text with EEA relevance)

2010/C 89/01

On 11 February 2010, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32010M5661. EUR-Lex is the on-line access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32010M5661. EUR-Lex is the on-line access to the European law.

---
Page 1 of 2

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

THEODORE WILLIAMS,

Plaintiff,

vs. Case No. 3:09cv371/LAC/CJK

W. MCNEAL, et al.,

Defendants.

________________________________________________________________

O R D E R

This cause comes on for consideration upon the magistrate judge’s Report and

Recommendation dated July 3, 2012. (Doc. 51). The parties have been furnished a

copy of the Report and Recommendation and have been afforded an opportunity to

file objections pursuant to Title 28, United States Code, Section 636(b)(1). No

objections have been filed.

Having considered the Report and Recommendation, I have determined that

the Report and Recommendation should be adopted.

Accordingly, it is now ORDERED as follows:

1. The magistrate judge's report and recommendation is adopted and

incorporated by reference in this order.

2. This cause is DISMISSED WITHOUT PREJUDICE for plaintiff’s

failure to prosecute and failure to comply with orders of the court.

Case 3:09-cv-00371-LC-CJK Document 53 Filed 08/10/12 Page 1 of 2
Page 2 of 2

3. The clerk is directed to close the file.

DONE AND ORDERED this 10 day of August, 2012.

th

s/L.A. Collier 

LACEY A. COLLIER

SENIOR UNITED STATES DISTRICT JUDGE

Case No: 3:09cv371/LAC/CJK

Case 3:09-cv-00371-LC-CJK Document 53 Filed 08/10/12 Page 2 of 2
Page 1 of 1

IN THE UNITED STATES DISTRICT COURT FOR THE

NORTHERN DISTRICT OF FLORIDA

PENSACOLA DIVISION

UNITED STATES OF AMERICA

v. Case No. 3:10cr107/MCR

RENE ORTEGA CALDERON

 /

ACCEPTANCE OF PLEA OF GUILTY

Pursuant to the Report and Recommendation of the United States Magistrate

Judge, to which there have been no timely objections, and subject to this Court’s

consideration of the Plea Agreement pursuant to Fed. R. Crim. P. 11, the plea of guilty of

the Defendant, RENE ORTEGA CALDERON, to Counts I and II of the Indictment is hereby

ACCEPTED. All parties shall appear before this Court for sentencing as directed.

DONE and ORDERED this 6th day of December 2010. 

 s/ M. Casey Rodgers 

M. CASEY RODGERS

UNITED STATES DISTRICT JUDGE
#### STATE v. WILLIAMS

No. 231 PC.

Case below: 33 N.C. App. 344.

Application by defendant for further review denied 31 August 1981.
Exhibit 32.1
                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Eagle Broadband, Inc. (the "Company") on
Form 10-K for the year ending August 31, 2003 as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), I, David Weisman, Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss. 1350, as
adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.

Date:  December 8, 2003

/S/David Weisman
----------------
David Weisman,
Chief Executive Officer
Exhibit 10.14


 


 


ASSIGNMENT


 


 





	ASSIGNOR:	Paul I. Bulat
	 	 	 
	ASSIGNEE:	American Doctors On-Line, Inc.
	 	 	200 Myles Standish Blvd.
	 	 	Tauton, Massachusetts 02780
	 	 	 
	STATE OF INCORPORATION OF ASSIGNEE:
	 	 	 
	INVENTION: 	System and Method for Delivering Medical Examination, 
	 	 	Diagnosis, and Treatment Over a Network 
	 	 	 
	ATTORNEY DOCKET:	2551/101 
	 	 	 
	SERIAL NO:	09/855,738 
	 	 	 
	FILED:	 	May 14, 2001







 


 


Assignor is the sole
inventor (if only one inventor is listed above) or a joint inventor (if more than one inventor is listed above) of the above invention
(the "Invention") described in a United States patent application (the "Application") bearing the above attorney
docket number and having as a title the above name for the Invention. The Application has a Patent and Trademark Office filing
date and serial number as indicated above, or if no filing date and serial number are shown, has a Declaration executed by Assignor
contemporaneously with this Assignment.


 


For valuable
consideration, receipt of which is acknowledged, each Assignor hereby assigns to Assignee (which term shall include Assignee's
successors and assigns), all of Assignor's
right, title and interest in the Invention, all improvements therein, the Application and all priority rights arising therefrom,
and any patents, and any reissues and extensions thereof,
which issue in any country upon any patent applications which correspond with any of the following: the Application, any divisional,
continuation-in-whole, or substitute United States application which is based on the Application; or any continuation-in-part
United States application (including 




    	 



    	 



    

divisions, continuations-in-whole
or -in-part, and substitutions thereof or therefor) based in-part on any of the above described applications.


 


Each Assignor
further agrees that such Assignor and Assignor's heirs
and legal representatives will, without further consideration, cooperate with Assignee in the prosecution of all of the above applications,
execute, verify, acknowledge and deliver all such further papers, including applications for patents and for reissues and extensions
therefor, and instruments of assignment and transfer thereof, and will communicate any facts known to Assignor relating to the
Invention, to obtain or maintain or enforce patents for the Invention and improvements therein in any and all countries and to
vest title thereto in Assignee. Each Assignor further agrees that such Assignor will, without further compensation to Assignor
during the term of such Assignor's employment by Assignee and thereafter for reasonable compensation as determined by Assignee,
perform such other acts as may be reasonably required when requested by Assignee, including
attending depositions, preparing and executing declarations and affidavits and testifying as a witness, to obtain or maintain or
enforce patents for the Invention and improvements therein in any and all countries and to vest title thereto in Assignee.
UNPUBLISHED UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT No. 00-2015

GEORGE R. “TEX” WOOD, Plaintiff - Appellant, versus CAMERON P. QUINN, Secretary of the Board of Elections, Commonwealth of Virginia, Defendant - Appellee.Appeal from the United States District Court for the Eastern District of Virginia, at Richmond. James R. Spencer, District Judge. (CA-00-335-3) Submitted: September 7, 2000 Decided: September 8, 2000 Before NIEMEYER, MOTZ, and TRAXLER, Circuit Judges. Affirmed by unpublished per curiam opinion. George R. “Tex” Wood, Appellant Pro Se. Mark L. Earley, Attorney General, James Walter Hopper, OFFICE OF THE ATTORNEY GENERAL OF VIRGINIA, Richmond, Virginia, for Appellee. Unpublished opinions are not binding precedent in this circuit. See Local Rule 36(c).2 PER CURIAM: George R. “Tex” Wood appeals from the district court’s ordergranting summary judgment for Defendant in Wood’s action challenging the constitutionality of Virginia’s requirements for inclusion on the ballot as an independent candidate for the United States Senate in the general election in Virginia. In light of the time-sensitive nature of the issues, we have granted Wood’s motion to expedite consideration of the appeal. We have reviewed the record and the district court’s opinion and find no reversible error. Accordingly, we deny Wood’s motion for an injunction pending appeal and affirm on the reasoning of the district court. See Wood v. Quinn , No. CA-00-335-3 (E.D. Va. July 17, 2000). We dispense with oral argument because the facts and legal contentions are adequately presented in the materials before the court and argument would not aid the decisional process.

AFFIRMED
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF FLORIDA

PANAMA CITY DIVISION

KELLY WHISBY,

Plaintiff,

vs. CASE NO. 5:10cv175/RS-EMT

JOHN DOE, Lieutenant of

Marianna Federal Prison, et al,

Defendants.

__________________________________/

ORDER

Before me is the Magistrate Judge’s Order, Report and Recommendation 

(Doc. 5). Plaintiff has not filed objections.

IT IS ORDERED:

1. The Magistrate Judge’s Order, Report and Recommendation is adopted

and incorporated in this Order.

2. Pursuant to 28 U.S.C. §1915(g), this case is dismissed without prejudice

to Plaintiff’s filing a new complaint which must be accompanied by

payment of the $350.00 filing fee in its entirety.

3. The clerk is directed to close the file.

ORDERED on September 17, 2010.

/S/ Richard Smoak 

RICHARD SMOAK

UNITED STATES DISTRICT JUDGE
_________________________________________ 

 

 

 

Order Michigan Supreme Court 

Lansing, Michigan 

February 27, 2006 Clifford W. Taylor,

 Chief Justice 

128201 Michael F. Cavanagh 

Elizabeth A. Weaver (47) Marilyn Kelly 

Maura D. Corrigan 

Robert P. Young, Jr. 

Stephen J. Markman, PEOPLE OF THE STATE OF MICHIGAN, Justices 

Plaintiff-Appellee, 

v SC: 128201 

 COA: 255405 

Livingston CC: 77-001715-FY

MONICA ANN JAHNER, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the motion for reconsideration of this Court's order of 

December 15, 2005 is considered, and it is DENIED, because it does not appear that the 

order was entered erroneously. 

l0221 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

February 27, 2006 

Clerk
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel; Mechanism of Transport of Secretary Vesicles.                    

*Date:*                         December 6, 2007.                    

*Time:*                         2 p.m. to 4 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6100 Executive Boulevard, 5B01, Rockville, MD 20852 (Telephone Conference Call).                    

*Contact Person:*                         Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institutes of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496-1485,                         *changn@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 3.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: November 7, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-5671 Filed 11-15-07; 8:45 am]

BILLING CODE 4140-01-M
# C_2010190EN.01001301.xml

| 14.7.2010 | EN | Official Journal of the European Union | C 190/13 |
| --- | --- | --- | --- |

14.7.2010

EN

Official Journal of the European Union

C 190/13

---

Euro exchange rates (1)

1

13 July 2010

2010/C 190/05

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,2569 |
| JPY | Japanese yen | 110,95 |
| DKK | Danish krone | 7,4555 |
| GBP | Pound sterling | 0,83180 |
| SEK | Swedish krona | 9,4033 |
| CHF | Swiss franc | 1,3337 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 7,9570 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,344 |
| EEK | Estonian kroon | 15,6466 |
| HUF | Hungarian forint | 277,80 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7087 |
| PLN | Polish zloty | 4,0748 |
| RON | Romanian leu | 4,2615 |
| TRY | Turkish lira | 1,9564 |
| AUD | Australian dollar | 1,4336 |
| CAD | Canadian dollar | 1,2978 |
| HKD | Hong Kong dollar | 9,7715 |
| NZD | New Zealand dollar | 1,7641 |
| SGD | Singapore dollar | 1,7357 |
| KRW | South Korean won | 1 524,23 |
| ZAR | South African rand | 9,5199 |
| CNY | Chinese yuan renminbi | 8,5117 |
| HRK | Croatian kuna | 7,1980 |
| IDR | Indonesian rupiah | 11 382,54 |
| MYR | Malaysian ringgit | 4,0252 |
| PHP | Philippine peso | 58,376 |
| RUB | Russian rouble | 38,6910 |
| THB | Thai baht | 40,683 |
| BRL | Brazilian real | 2,2099 |
| MXN | Mexican peso | 16,0698 |
| INR | Indian rupee | 58,7660 |

Currency

Exchange rate

USD

US dollar

1,2569

JPY

Japanese yen

110,95

DKK

Danish krone

7,4555

GBP

Pound sterling

0,83180

SEK

Swedish krona

9,4033

CHF

Swiss franc

1,3337

ISK

Iceland króna

NOK

Norwegian krone

7,9570

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,344

EEK

Estonian kroon

15,6466

HUF

Hungarian forint

277,80

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7087

PLN

Polish zloty

4,0748

RON

Romanian leu

4,2615

TRY

Turkish lira

1,9564

AUD

Australian dollar

1,4336

CAD

Canadian dollar

1,2978

HKD

Hong Kong dollar

9,7715

NZD

New Zealand dollar

1,7641

SGD

Singapore dollar

1,7357

KRW

South Korean won

1 524,23

ZAR

South African rand

9,5199

CNY

Chinese yuan renminbi

8,5117

HRK

Croatian kuna

7,1980

IDR

Indonesian rupiah

11 382,54

MYR

Malaysian ringgit

4,0252

PHP

Philippine peso

58,376

RUB

Russian rouble

38,6910

THB

Thai baht

40,683

BRL

Brazilian real

2,2099

MXN

Mexican peso

16,0698

INR

Indian rupee

58,7660

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “Host Response to Pathogens”.                    

*Date:*                         January 10, 2008.                    

*Time:*                         1 p.m. to  5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Rockledge 6700, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call).                    

*Contact Person:*                         Lynn Rust, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-402-3938,                         *lr228v@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: December 11, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-6084 Filed 12-19-07; 8:45 am]

BILLING CODE 4140-01-M